Skip to search formSkip to main contentSkip to account menu

hematide

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

PeptidesPolyethylene Glycolssynthetic peptide-based erythropoiesis stimulating agent

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes.
Erythropoietin (EPO) and other erythropoiesis-stimulating agents possess a high misuse potential in elite sport due to their… 
2010
2010
Erythropoiesis Equivalence, Pharmacokinetics and Immune Response following Repeat Hematide™ Administration in Cynomolgus Monkeys
Hematide™ is a synthetic PEGylated peptidic erythropoiesis stimulating agent (ESA) that is presently being developed for the… 
2009
2009
Chronic Pharmacological and Safety Evaluation of Hematide™, a PEGylated Peptidic Erythropoiesis-Stimulating Agent, in Rodents
Hematide™ is a synthetic peptide-based, PEGylated erythropoiesis-stimulating agent, which is being developed for the chronic… 
2008
2008
Preclinical Safety and Pharmacology of Hematide™, a Peptidic Erythropoiesis Stimulating Agent (ESA), in Rats and Monkeys
The pharmacology, toxicokinetics, and safety of HematideTM, a synthetic peptidic erythropoiesis-stimulating agent (ESA), were… 
2008
2008
Preclinical safety and pharmacology of Hematide, a peptidic erythropoiesis stimulating agent (ESA), in rats and monkeys.
The pharmacology, toxicokinetics, and safety of Hematide, a synthetic peptidic erythropoiesis-stimulating agent (ESA), were… 
2007
2007
Correction of Anemia with Hematide™, a Synthetic Peptide-Based Erythropoiesis Stimulating Agent (ESA), in Oncology Patients Receiving Chemotherapy.
Introduction: Hematide™ a novel, synthetic, PEGylated peptidic compound, binds to and activates the erythropoietin receptor. It… 
Review
2006
Review
2006
Recent advances in erythropoietic agents in renal anemia.
2006
2006
Chronic Preclinical Safety Evaluation of Hematide™, a PEGylated Peptidic Erythropoiesis Stimulating Agent, in Monkeys.
Hematide, a synthetic PEGylated peptidic compound specifically binds and activates the erythropoietin receptor thereby… 
2005
2005
Hematide™, a Synthetic Peptide-Based Erythropoiesis Stimulating Agent (ESA), Demonstrates Erythropoietic Activity in a Phase 2 Single Dose, Dose Escalating Study in Patients with Chronic Kidney…
Hematide is a PEGylated synthetic peptidic ESA that binds to and activates the erythropoietin (EPO) receptor. It has demonstrated… 
2004
2004
Preclinical Evaluation of Hematide™, a Novel Erythropoietic Receptor Agonist for the Treatment of Anemia Caused by Kidney Disease.
Hematide™ is a PEGylated synthetic dimeric peptide. Initial peptide sequences were identified by screening a human erythropoietin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)